Crossmark

The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells

Crossref DOI link: https://doi.org/10.1186/s12885-016-2621-6

Published: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cho, Christina

Horzempa, Carol

Jones, David

McKeown-Longo, Paula J.
Funding

Funding for this research was provided by:

National Institutes of Health (CA058626)

U.S. Department of Defense (LC090169)
License Information

Text and Data Mining valid from 2016-08-02

Version of Record valid from 2016-08-02
More Information

Article History

Received: 15 January 2016

Accepted: 26 July 2016

First Online: 2 August 2016

Document is current

Any future updates will be listed below